Stockhead’s Investor Presentation gives executives of emerging ASX-listed companies the opportunity to present their latest investor presentation to current and potential investors.

This week, Stockhead heard from Dr Nina Webster Nina Webster, CEO and Managing Director of Dimerix (ASX:DXB)

Dimerix is a biopharmaceutical company developing innovative new therapies in areas with unmet medical needs.  Dimerix comprises two entitiesDimerix Limited (ASX:DXB) and Dimerix Biosciences Pty Ltd.

Dimerix has successfully used the Receptor-HIT technology to identify a novel treatment (DMX-200) that may transform the lives of patients with Kidney Disease.